Evidence map›Paper›PMID 41162811›Full record

ReviewMolecular biomedicine2025

ROS homeostasis in cell fate, pathophysiology, and therapeutic interventions.

Yuan-Shen Chen, Hui-Xiang Tian, Ding-Chao Rong, Luozixian Wang, Shan Chen, Jun Zeng, Heng Xu, Jie Mei, Lei-Yun Wang, Yu-Ligh Liou and 1 more

Abstract readReview
In one paragraph

Review in Molecular biomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Rethinking Oxidative Stress inLife (Basel, Switzerland) · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuan-Shen Chen *Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, People's Republic of China.
Hui-Xiang Tian *Department of Clinical Pharmacology, Xiangya Hospital, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, 410008, People's Republic of China.
Ding-Chao Rong *Department of Orthopedics, The First Affiliated Hospital of Shaoyang University, Shaoyang, Hunan, 422000, People's Republic of China.
Luozixian WangCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, VIC, Australia.
Shan ChenState Key Laboratory of Oncogenes and Related Genes, Department of Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, People's Republic of China.
Jun ZengDepartment of Thoracic Surgery, Xiangya Hospital, Central South University, Changsha, Hunan Province, 410008, People's Republic of China.
Heng XuTianfu Jincheng Laboratory, Chengdu, Sichuan, 610052, People's Republic of China.
Jie MeiDepartment of Clinical Pharmacology, Xiangya Hospital, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan, 410008, People's Republic of China. meijie7201@163.com.
Lei-Yun WangDepartment of Pharmacy, Traditional Chinese and Western Medicine Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, Wuhan, 430022, People's Republic of China. 15974276030@163.com.
Yu-Ligh LiouKey Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, People's Republic of China. pedro.liou@gmail.com.ORCID http://orcid.org/0000-0003-3994-6250
Hong-Hao ZhouKey Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, People's Republic of China. hhzhou2003@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) homeostasis is an essential process that enables cells dynamically regulate their ROS levels, thereby ensuring survival and the execution of diverse physiological functions. ROS, a group of highly reactive molecules that serve as both critical signaling molecules and potential toxic agents, are central regulators of this process. Dysregulation of ROS homeostasis can impair cellular and organismal physiology, ultimately contributing to disease pathogenesis, which is a phenomenon observed throughout the lifespan. However, the precise mechanisms underlying these processes remain poorly understood, and the therapeutic potential of targeting ROS homeostasis regulation for disease intervention has not been systematically elucidated. This review provides a comprehensive overview of the diverse roles of ROS and their metabolic associations. It offers an in-depth discussion of the regulatory mechanisms underlying ROS homeostasis and their influence on processes such as cellular metabolism, cell death, and cell survival. By modulating cell fate, ROS play a broad and integral role in the pathogenesis of various diseases. Finally, this review systematically summarizes therapeutic interventions targeting ROS homeostasis. By elucidating the critical roles of ROS homeostasis in cellular physiology and disease treatment, this review aims to advance the discovery of potential biomarkers as well as the development of novel therapeutic approaches based on ROS homeostasis.

Indexed as

HomeostasisReactive Oxygen SpeciesAnimalsHumansOxidative StressSignal TransductionReactive Oxygen Species

Identifiers

PMID41162811
PMCPMC12572517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.